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Summal-y 
R.ANTES (regulated on activation, normal T expressed and secreted) is a member of the chemotactic 
cytokine (chemokine) ~/subfamily.  High affinity receptors for RANTES have been identified 
on a human monocytic leukemia cell line THP-1, which responded to RANTES in chemotaxis 
and calcium mobilization assays. Steady-state binding data analyses revealed approximately  700 
binding sites/cell on THP-1 cells with a Kd value of 400 pM, comparable to that expressed on 
human peripheral blood monocytes.  The RANTES binding to monocytic cells was competed 
for by monocyte chemotactic and activating factor (MCAF) and macrophage inflammatory protein 
1 (MIP-1) c~, two other chemokine ~ cytokines. Although MCAF and MIP-loL competed for 
R.ANTES binding to monocytes with apparent lower affinity (with estimated Kd of 6 and 1.6, 
nM respectively) both of these cytokines effectively  desensitized the calcium mobilization induced 
by RANTES. The chemotactic response of THP-1 cells to RANTES was also markedly inhibited 
by preincubation with MCAF or MIP-lcr  In contrast,  R.ANTES did not desensitize the THP-1 
calcium mobilization and chemotaxis in response to MCAF or MIP-lc~. These results, together 
with our previous observations that RANTES did not compete for MCAF or MIP-lot binding 
on monocytic cells, indicate the expression of promiscuous receptors on monocytes that recognize 
one or more cytokines within the chemokine B family. 
A  number of cytokines in the 8-11-kD  molecular mass 
range  have  recently been  identified  that  selectively 
chemoattract leukocyte subpopulations in vitro and elicit the 
accumulation of inflammatory cells in vivo. These cytokines 
belong to a superfamily of platelet 4 (PF4)-related molecules 
now known as chemokines (1). The chemokines are further 
divided into two subsets characterized by the positioning of 
the  first  two  closely  paired  cysteines. Members  of  the 
chemokine ot subfamily, represented by IL-8/neutrophil  ac- 
tivating protein 1 (NAP-l)  1 have an intervening amino acid 
between the first two cysteines (C-X-C) and are mainly neu- 
trophil targeted (1), whereas members of the chemokine fl 
subfamily, represented by monocyte chemotactic and activating 
1 Abbreviations used in  this paper: MCAF,  monocyte chemotactic  and 
activating  factor;  MCP-1,  monocyte chemotactic  protein  1;  MIP-lo~, 
macrophage inflammatory protein log NAP-l, neutrophil activating protein 
1; R.ANTES, regulated on activation, normal T expressed and secreted; 
rh, recombinant  human. 
factor (MCAF)/monocyte chemotactic protein 1 (MCP-1), 
have a C-C configuration and chemoattract mononuclear cells 
(1, 2). RANTES (regulated on activation, normal T expressed 
and secreted) (2) is a peptide that belongs to the chemokine 
B subfamily  and was originally cloned from a subtracted eDNA 
library made from RNA isolated from a functional, nontrans- 
formed, antigen-stimulated  T cell line (3). The recombinant 
R.ANTES protein is a highly basic, 8-kD polypeptide that 
chemoattracts human peripheral blood monocytes and T lym- 
phocytes of the CD4 +/CD45 RO + phenotype in vitro (4). 
R.ANTES has also been reported to rapidly stimulate Ca  2+ 
mobilization and histamine release in human basophils and 
act as a chemoattractant for human eosinophils  (5, 6). 
In this  study,  we investigated  the specific receptors  for 
R.ANTES and explored the functional interrelationships be- 
tween the binding and functional effects of recombinant 
human (rh) RANTES and other chemokine/3 cytokines on 
monocytic cells. We demonstrate that both human MCAF 
and macrophage inflammatory protein lo~ (MIP-lcz) were 
capable of competing for 12s-I-RANTES binding to mono- 
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the  monocytic cell  response  to  R.ANTES  in both  Ca  2+ 
mobilization and chemotaxis assays. The results suggest the 
expression of a RANTES receptor species on monocytic cells 
which binds and transduces signals  in response to several 
members of the chemokine B subfamily. 
Materials  and Methods 
Cytokines.  rhRANTES  and rhMCAF were purchased from 
Pepro Tech Inc. (lot. 8721; Rocky Hill, NJ). Two radioiodinated 
rhRANTES preparations with the 12sI located on either histidine 
or tyrosine  residues  were  kindly provided  as a gift from Dr. B. Brown 
(DuPont NEN, Boston, MA). Both preparations have a specific 
activity of 5  x  10  s cpm/ng protein. The sources of other cyto- 
kines are: rhMIP-lc~ from Dr. M. Tsang (R & D Systems, Inc., 
Minneapolis, MN); rhlL-8 (Dainippon Pharmaceutical Co. Ltd., 
Osaka, Japan; and rhGRO (Pepro Tech). 
Cells.  Human acute monocytic leukemic cell line THP-1 was 
obtained from the American Type Culture Collection (RockviUe, 
MD) and maintained in RPMI 1640 medium (Whittaker M. A. 
Bioproducts, Walkersville,  ME)) supplemented  with 10% FCS (Hy- 
clone Laboratories,  Logan, UT) and penicillin/streptomycin.  Human 
peripheral blood monocytes were purified from normal blood (Na- 
tional Institutes of Health Clinical Center Transfusion Medicine 
Department, Bethesda, MD) with an isoosmotic  Percoll (Pharmacia, 
Uppsala, Sweden) gradient as described elsewhere (7). The mono- 
cyte preparations were always  >90% pure as assessed  by morpho- 
logical criteria. 
Chemotaxis Assay.  Cell migration was evaluated using a 48- 
well microchemotaxis chamber technique (8). A 25-/A aliquot of 
testing reagents diluted in RPMI 1640 with I mg/ml BSA was 
placed in the lower compartment, and 50/zl of cell suspension (1.5 
x  106/ml monocytes or 4  x  106/ml THP-1 cells) was placed in 
the upper compartments of the chamber. The two compartments 
were separated  by the polycarbonate  filter (5-#m pore size; Nucleo- 
pore Corp., Pleasanton, CA). After incubation at 37~  (90 rain 
for monocytes and 120 rain for THP-1 cells) in air with 5% CO2, 
the filter was removed, fixed, and stained with Diff-Quik (Harleco, 
Gibbstown, NJ), and the number of migrating cells in five high- 
power fields were counted. The mean (+SD)  from one of three 
representative experiments are presented. The statistical  significance 
of the number of cells migrating in response to stimuli vs. base- 
line (migration  toward control  medium) was  calculated using 
Dunnett's test. 
Binding  of  12SI-RANTES  to  Human  Cells.  In  steady-state 
binding assays, 2 x  106 cells were incubated in duplicate with in- 
creasing concentrations of the test substance  in a modified  binding 
medium (RPMI 1640 containing 1 mg/ml BSA and 25 mM Hepes, 
pH 7.4) in a total volume of 200 #1. The nonspecific  binding was 
determined by parallel  incubation in the presence of 100-fold excess 
of unlabeled RANTES. After incubation at 4~  for 4 h, the cells 
were pelleted through a 10% sucrose/PBS cushion. The tips of 
the tubes containing cells were cut and radioactivity was deter- 
mined in a gamma counter (model 4000; Beckman Instruments, 
Inc., Fullerton, CA). The residual nonspecific  bound radioactivity 
associated with cells in the presence of unlabeled RANTES was 
subtracted from total bound radioactivity to yield specific  binding. 
For estimation of binding  sites/cell and Kd value, a nonlinear 
regression calculation described by Bates and Watts (9) was used. 
The advantage of this method is to minimize the difference be- 
tween the model and the available data in the least-squares sense. 
In all cases, complete data generated in the assay  was used in the 
regression analyses.  Scatchard  plots were reformatted presentation 
of  the nonlinear regression. Although some of our data might hint 
at a more complex model (10), no significant improvement was 
achieved using models other than "one receptor species" model at 
the  present time.  The  displacement curves of  mI-RANTES 
binding to monocytic cells by different cytokines were generated 
by incubating cells with a constant concentration of 12SI-RANTES 
for 4 h at 4~  in the presence of increasing amounts of unlabeled 
ligands. The cells were then pelleted through a sucrose cushion 
and the residual radioactivity determined. 
Analysis of Intracellular Calcium Mobilization.  Analysis  of the 
changes in intracellular Ca  2§  concentration ([Ca2+]i) of THP-1 
cells was carried out using a photometer (Deltascan; Photon Tech- 
nologies International,  Inc., Princeton, NJ) as described (11). Briefly, 
THP-1 cells were incubated at a density of 107/ml for 30 rain at 
37~  in medium containing 5 #m lndo-lAM (Molecular Probes, 
Inc., Eugene, OK). After 30 rain, fresh medium was added  diluting 
the cells to 5  x  106/ml, and the cells were further incubated for 
30 min at 37~  Cells were washed  once with medium after loading 
with Indo-1, and held at room temperature in the dark until anal- 
ysis. The [Ca2+]i was monitored with the Indo-1 loaded cells sus- 
pended at 37~  in Dulbecco's PBS with Ca  2+  and Mg  2.  sup- 
plemented with 5 mM glucose. Indo-1 excitation was at 358 nm 
with detection of bound dye at 402 nm (violet) and free dye at 
486 (blue). 
Results 
RANTES has previously been reported to be chemotactic 
for human peripheral blood monocytes and T  lymphocytes 
(4).  We obtained monocyte chemotactic responses  over  a 
similar dose range using commercially available rhRANTES. 
We subsequently examined the capacity of R.ANTES to ac- 
tivate the monocytic cell line THP-1. THP-1 cells were de- 
rived from an acute monocytic leukemia patient and have rare 
chromosomal abnormality (12). THP-1 ceUs were cultured 
in suspension and express abundant receptor sites for both 
MCAF and MIP-lo~ (13). In preliminary experiments, we ob- 
served that THP-1 cells, even while undergoing exponential 
growth, migrated through polycarbonate falters in response 
to a variety of chemotactic agents including bacterial peptide 
formyl-methionyl-leucyl-phenylalanine  (fMLP) (Sigma Im- 
munochemicals, St. Louis, MO), MCAF, and MIP-lol, but 
not to IL-8, which preferentially chemoattracts neutrophils 
and is a chemokine o~ subfamily member. As shown in Fig. 1, 
rhRANTES also induced THP-1 cell migration in a dose- 
dependent manner with a typical bell-shaped curve. The max- 
imal induction of THP-1 cell migration by rhRANTES was 
obtained with 6-60 nM of the cytokine (Fig.  1). 
The chemotactic rather than chemokinetic nature of THP-1 
cell migration to rhRANTES was confirmed by checkerboard 
analysis (Table 1) in which the maximal induction of THP-1 
cell migration by rhRANTES occurred always in the pres- 
ence of a positive cytokine concentration gradient between 
the upper and lower wells of the chemotaxis chamber (higher 
concentration below the falter). In the presence of negative 
gradients, no directional migration was observed.  At iden- 
tical concentrations above and below the filter, little enhance- 
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Chemotacttc response of THP-I cells reduced by rhRANTES 
and related cytokmes The chemotaxts assays were performed as descnbed 
m the Matenals and Methods  The results are from one representatwe ex- 
penment out of five performed  SD values were <15% of each mean value 
and were not plotted 
ment of THP-1 cell migration was observed, suggesting that 
RANTES has no chemokinetic effect on THP-1 cell migration. 
We next exammed the presence of specific receptors for 
rhRANTES  on monocytic cells.  The binding capacity of 
t2SI-RANTES by THP-1 cells showed a temperature depen- 
dence with higher (fourfold) ligand association at 37~  than 
at 4~  (Fig. 2). An intermediate ligand association with cells 
was observed at 22~  Binding at 37~  and 22~  reached 
a maximum at 20 mm (Fig. 2) and was associated with inter- 
nalization of the ligand-receptor complex (data not shown). 
Assays performed at 4~  lead to specific ligand binding to 
the cell membrane since most of the bound ligand could be 
eluted from the cells by a brief exposure of the cells to 50 
mM glycme-HCl (pH 3, data not shown). Maximal bindmg 
at 4~  without internalization was obtained after 4 h at 4~ 
Consequently  the  receptor  number  and  the  affimty  for 
RANTES were determined at 4~ 
The binding isotherms of THP-1 cells (Fig.  3 a), as well 
as peripheral blood monocytes (Fig.  3 b) for 12sI-RANTES 
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Figure  2.  Bmchng kinetics of racholabeled RANTES to THP-1 cells 
2  x  106 THP-1 cells (m 200 t~l bmchng me&urn) were incubated m duph- 
cates with 0 1 nM 12SI-RANTES m the presence or absence of 100-fold 
excess of unlabeled rhRANTES at &fferent temperature condmons for 
the m&cated time periods and assayed  as clescrtbed  m Materials and Methods 
A  representauve experiment out of the three performed ts shown 
was determined. Steady-state bmding data analyses revealed 
",,700 lugh-affinity binding sites/cell for RANTES on THP-1 
cells with a Kd value of 400 pM. Similar receptor numbers 
and Kd values were detected on peripheral blood monocytes. 
Human peripheral blood neutrophils that do not migrate to 
RANTES  failed  to  show  any  specific  binding  sites  for 
R.ANTES (data not shown). Thus, the presence of specific 
cell surface receptors for R.ANTES on monocytes directly 
correlates with their chemotactic reactivaty to this chemokine. 
The ligand specificity of RANTES receptors on mono- 
cytic cells was investigated in competition studies using var- 
ious  unlabeled  ligands  including  several  members  of the 
chemokine superfamily. Cytokines including IL-lo~, TNF, 
G-CSF,  GM-CSF, MCSF,  and the bacterial peptide f'MLP, 
as well as chemokme cx (C-X-C) cytokines such as II~8 and 
Table  1.  Checkerboard  Analysts of RANTES  Chemotactic Acamt 7 for THP-I  Cells 
R.ANTES  m  lower  wells 
R.ANTES  m  nM 
upper  wells  0  0.12  1 2  6  12 
nM 
0  58  _+  7  81  _+  5  104  +  14"  155  +  17"  163  _+  11" 
0.12  52  _+  3  59  _+  8  76  _+  8  104  +  12"  155  +  9* 
1.2  46  _+  8  53  _+  4  61  _+  8  89  _+  11  121  _+  13" 
6  42  +  5  39_+  6  48  _+  7  57  +  12  78  _+  6 
12  33  _+  7  46  +  8  49  _+  10  59  +  11  67  _+  4 
Different concentrations of rhRANTES were placed m the upper and/or lower wells of the chemotaxls chamber  THP-1 ceils (50 #1 at 4  x  106/ml) 
were placed m the upper wells  The chemotaxts assay was performed as described  m Materials and Methods  Results are representanve of three expert- 
meats performed 
* p  <  0 05 vs  control (with medmm m  the upper and lower wells) 
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Figure  3.  Steady-state binding of t2SI-RANTES  to monocyuc cells  2 
x  106 THP-1 cells (.4) or Percoll-punfied peripheral blood monocytes  (B) 
in 200/~l binding medium were incubated at 4~  for 4 h with increasing 
concentrauons  of nSI-RANTES  The parallel duplicate  tubes contained 
100-fold  excess of unlabeled  rhKANTES and were assayed as described 
in Materials and Methods  (Insets) Reformatted Scatchard plots of the non- 
linear regression  calculauon 
melanoma growth stimulatmg activity, did not compete for 
RANTES binding to monocytic cells (data not shown). In 
contrast, rhMCAF and MIP-lo~, two members of the chemo- 
kine  3  (C-C)  subfamily, were  capable of competing  for 
RANTES bmdmg to THP-1 cells (Fig. 4) as well as on mono- 
cytes (data not shown). The displacement curves show that 
unlabeled rhRANTES competed  for t2SI-RANTES with a 
similar affinity as determined in the steady-state binding assays 
(300 vs. 400 pM). rhMCAF competed for RANTES binding 
with apparent lower affimty (about 6 nM), whereas rhMIP-lc~ 
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Figure  4.  Displacement of t25I-RANTES  bmdmg to THP-1 cells by 
unlabeled RANTES, MCAF,  and MIP-lcx  Duphcate  samples of 2  x  106 
THP-1 cells m 200 #1 bmdmg medium were incubated with 0 1 nM 1251- 
RANTES in the presence of increasing quantities of unlabeled cytokines 
After incubation at 4~  for 4 h, the cells were centrifuged  through su- 
crose cushion and the radioactmty in cell pellets was measured  Five ex- 
periments  were performed  with stmdar results 
(about 6 nM), whereas rhMIP-hx competed for RANTES 
receptors with an intermediate affinity (about  1.6 riM). 
We next performed crossdesensitization expemnents m cal- 
cium mobilization and chemotaxis assays to establish the func- 
tional significance of RANTES receptor utilization by MCAF 
and MIP-lcz. Transient increases m cytosohc free calcium is 
an early event in signal transduction during leukocyte activa- 
uon with chemotactic  agonists  (14-17).  As shown in Fig. 
5, all recombinant chemotactic cytokines for THP-1 cells in- 
duced rapid calcium  mobdizauon in  these cells, although 
RANTES was less potent as compared with the same con- 
centration of MCAF or MIP-lo~ (F,g. 5 A). Prior incubauon 
of the cells with mammally effective doses of RANTES (60 
nM) did not prevent the subsequent response to 12 nM MCAF 
(Fig. 5 B) or MIP-loe (Fig. 5 C). In contrast, the subsequent 
response to 12 nM rhRANTES was abolished when the cells 
were miuaUy stimulated w,th 60 nM MCAF (Fig. 5 B) or 
MIP-lo~ (Fig. 5 C)  fMLP  did not show any crossdesensitizing 
effect  on  the  P.ANTES  response (data not  shown).  The 
umdlrect,onal  desensiuzat,on  of rhKANTES by rhMCAF 
or rhMIP-lol was also observed m chemotaxis  assays (Table 
2)  Premcubauon of THP-1  cells for 30 mm at 37~  with 
30 nM rhRANTES did not markedly reduce the cell m,gra- 
tlon m response to either 6 nM rhMCAF or MIP-loc How- 
ever, premcubauon of cells with 30 nM rhMCAF or MIP-lo~ 
markedly inhibited  the cell migration  to rhRANTES. 
Discussion 
R.ANTES  has prev,ously been shown to reduce in vitro 
chemotaxis  in monocytes  and CD45 § T  cells (4)  and is a 
member of the chemokine 3  subfamily. We have confirmed 
and extended  these observauons using  commercially  avail- 
able rhRANTES to reduce m v,tro  chemotaxis  of human 
peripheral blood monocytes  and the human acute leukem,a 
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cell line THP-1. In addition to being chemotactic for mono- 
cytic cells, rhRANTES also induced calcium mobilizauon 
m THP-1 cells. We therefore utilized this cell hne as a more 
homogeneous cell source to further characterize binding of 
12sI-RANTES to cell surface receptors. 
Our initial experimental attempts to Identify RANTES 
receptors at 4~  with conventional binding medium that was 
previously used to characterize ID8 (18) and MIP-lc~ or MllXl~ 
(13) receptors were not successful. Increasing concentrations 
of unlabeled rhRANTES paradoxically yielded increased ad- 
sorption of radioactivity to cells. By optimizing binding con- 
ditions using a lower concentration of the carner protein BSA 
(1 mg/ml) and slightly higher pH (pH 7.4),  we detected 
specific competitive binding of 12SI-KANTES on THP-1 
cells, as well as on peripheral blood monocytes. Steady-state 
binding data analyses revealed a single class of high-affinity 
receptors on THP-1 cells and human peripheral blood mono- 
cytes with '~700 binding sites/cell and a Kd value of 400 
pM. The requirement for lower carrier  protein concentra- 
tion and higher pH may be based on a reduction in nonspecific 
aggregate formation by this highly basic peptide cytokine, 
as  has  been  seen  for other ligands for  the chemokine/3 
family (19). 
Of the many unlabeled ligands tested, only MCAF and 
MIP-lot, two members of the chemokme B subfamdy, com- 
peted for 12SI-RANTES binding to THP-1 cells. Although 
the affinity of MCAF and MIP-lot for KANTES receptor 
is lower (6 and 1.6 riM, respectively) when present in excess, 
both MCAF and MIP-lot effecuvely blocked 12SI-RANTES 
Figure  5.  Desens1tization of R.ANTES induced Ca  2  + moblhzauon by 
MCAF and MIP-lc~  (A) the [Ca2+], of Indo-l-loaded THP-1 cells was 
monitored as they were stimulated  with rhMCAF (60 nM), rhMIP-lc~ 
(60 nM), or rhRANTES (60 nM), where indicated  (B) THP-1 cells were 
stanuhted with 60 nM rhMCAF followed 100 s later by 12 nM rhRANTES 
(left trace) or 60 nM rhlLANTES followed 100 s later by 12 nM rhMCAF 
(right trace) (C) THP-1 cells were stimulated  with 60 nM rhMIP-lc~ fol- 
lowed 100 s later by 12 nM rhRANTES (left trace), or 60 nM rhRANTES 
followed by 12 nM rhMIP-lc~ (right trace) 
Table  2.  Desensittzat,on  of rhRANTES  Chemotactzc Activtty for  THP-I  Cells 
Number  of migrated cells (%  reduction*) 
Pretreatment 
of cells  Medium  R.ANTES  MCAF  MIP-lot 
Medmm  67  _+  5  220  _+  23  275  _+  29  254  _+  31 
R.ANTES  82  _+  11  105  _+  6  (75)*  264  _+  18  (5)  240  _+  19  (7) 
MCAF  79  +  12  118  _+  7  (66)*  122  _+  12  (72)*  203  _+  21  (27)* 
MIP-lc~  84  _+  6  122  _+  12  (64)*  236  +  31  (19)*  119  _+  17  (72)* 
THP-1 cells (5  x  106/ml)  were incubated  with assay medmm (control)  or dtfferent  cytokmes (at 200 ng/ml) for 30 mm at 37~  washed,  then 
resuspended m assay me&urn  50 pl of cell suspension were placed m the upper wells of the chemotaxls  chamber  The lower wells contained  control 
medmm or 50 ng/ml of cytokmes  The assay was  performed as described  m  Materials  and Methods 
* Percent  mhlbmon of chemotaxls  was  calculated with the formula  1  -  [mlgrauon of treated  cells to cytokmes  -  medmm control)/(mlgratlon 
of untreated cells to cytokmes  -  medmm control)]  x  100/100 
* p  <  0 05 compared  with the mlgrauon of untreated cell to respecuve  cytokmes 
703  Wang et al binding  to  monocytlc  cells.  To  examine  the  functional 
sigmficance of these binding results,  we performed a series 
of desensitization (or deactivation) experiments.  Pretreatment 
of THP-1 cells with MCAF or MIP-lot abolished the response 
to subsequent stimulation with P.ANTES m calcium mobili- 
zation assays. MCAF and MIP-lot also greatly reduced direc- 
tional cell migration induced by RANTES. In contrast, prior 
treatment with R.ANTES did not have a slgmficant effect 
on THP-1 cell responses to MCAF or MIP-lot in either cal- 
ctum mobilization or chemotaxis assays. This unilateral desen- 
sltizatton was presumably based on the quantitative differ- 
ence in receptor numbers for those chemokines on monocytes. 
The 700 P.ANTES receptors/cell  were probably too few to 
desensmze responses  of cells expressing 18,000 MCAF and 
3,000  MIP-lot receptors  per cell. 
In a previous study we identified specific binding sites on 
both circulating monocytlc cells and THP-1  ceils for 1251- 
MCAF and I?SI-MIP-lc~, as well as a third species which ap- 
parently bound both MCAF and MIP-lot (13) This, together 
with the present observations,  suggest the presence of at least 
three distract receptors for chemokine ~ subfamdy members 
on monocytlc THP-1 cells: (a) a RANTES receptor that binds 
three different ligands, tLANTES, MCAF, and MIP-lc~; (b) 
a umque receptor for MIP-lc~; and (c) a umque receptor that 
binds MCAF, but not RANTES or MIP-lo~. The R.ANTES 
receptor expressed  on monocytlc cells therefore appears  to 
be promiscuous in nature m  that it brads multiple ligands 
(RANTES, MIP-lot, and MCAF). Similar binding charac- 
teristics have been observed for one of the two Ib8 receptors 
that interact with multiple ligands from the chemokme c~ 
subfamdy (20-22)  Although the present study suggests the 
binding of muluple hgands (RANTES, MCAF, and MIP- 
lc~) to a smgle receptor for RANTES, it is possible that these 
homologous cytokines may bind a common receptor subunit 
which Is competed for by one of the hgands, as m the case 
of IL-3 and GM-CSF binding (23,  24).  Alternatively, these 
receptors  may transduce signals through a common G pro- 
tein whose quantity may be limiting; the ligand binding could 
be dependent on the association  of this molecule wtth the 
receptor.  This latter possibility is unlikely since treatment 
of monocytic cells with pertussts  toxin, a G protein inhib- 
Itor, abolishes chemotaxis and calcium mobilization, but does 
not affect  R.ANTES receptor binding or competition by 
MCAF and MIP-lot. We are currently cloning the receptor 
genes for these members of the chemokme B subfamily to 
gain additional insight into the molecular architecture respon- 
sible for hgand-specific and promiscuous binding phenomena. 
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